Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa®) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE | boehringer-ingelheim.cn

DOWNLOAD PDF (594.94 KB)

Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa®) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE

View PDF of Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa®) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE